Showing results (61-70 of 203) with videos related to
Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|October 18, 2002
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacityKirsten L White, Nicolas A Margot, Terri Wrin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2015
Baseline antiretroviral resistance mutations and treatment-emergent resistance in HIV-1 RNA-suppressed patients switching to EVG/COBI/FTC/TDF or continuing on their PI-, NNRTI-, or RAL-based regimenKristen Andreatta, Rima Kulkarni, Michael E Abram, et al.Antiviral Chemistry & Chemotherapy|March 7, 2008
The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65r+M184VJohn K Ly, Nicolas A Margot, Holly L MacArthur, et al.Antimicrobial Agents and Chemotherapy|June 28, 2006
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virusWilliam E Delaney, Adrian S Ray, Huiling Yang, et al.The Journal of Biological Chemistry|December 19, 2006
HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitroJay A Grobler, Geetha Dornadula, Michele R Rice, et al.Plos One|July 21, 2012
Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutationsMark A Winters, Robert M Lloyd, Robert W Shafer, et al.Journal of Clinical Microbiology|September 29, 2006
MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samplesEvguenia S Svarovskaia, Michael J Moser, Andrew S Bae, et al.Analytical Biochemistry|August 19, 2014
Development of a sensitive amplified luminescent proximity homogeneous assay to monitor the interactions between pTEFb and TatChristine Burlein, Carolyn Bahnck, Triveni Bhatt, et al.AIDS (London, England)|August 12, 2011
Switching between raltegravir resistance pathways analyzed by deep sequencingRithun Mukherjee, Shane T Jensen, Frances Male, et al.Antiviral Research|January 31, 2017
Antiviral response and resistance analysis of treatment-naïve HCV infected patients receiving multiple doses of the NS3 protease inhibitor GS-9256Hongmei Mo, Charlotte Hedskog, Eric Lawitz, et al.Pageof 21